Annals of Oncology
Annals of Oncology[edit | edit source]
Annals of Oncology is a peer-reviewed medical journal specializing in oncology, published by Oxford University Press. It serves as the official journal of the European Society for Medical Oncology (ESMO). The current editor-in-chief is Professor Fabrice André, based in Villejuif, France.
Some articles are available for free public access.
Before coming to Oxford University Press, the journal was published by Springer Science+Business Media
Overview[edit | edit source]
The Annals of Oncology was established to disseminate significant clinical and translational research in oncology, with an emphasis on innovative studies contributing to the understanding and treatment of cancer. The journal aims to provide a platform for oncologists and researchers to share findings that have the potential to impact cancer care globally.
Publication Details[edit | edit source]
- Publisher: Oxford University Press
- Frequency: Monthly
- ISSN: XXXX-XXXX
Impact[edit | edit source]
The journal is renowned for its high impact factor, making it one of the leading publications in the field of oncology. It is instrumental in advancing the scientific foundation of oncology through rigorous peer-review and a commitment to high standards in research publication.
Editorial Board[edit | edit source]
The editorial board, led by Professor Fabrice André, comprises a diverse group of leading oncologists and researchers from around the world. This board ensures the journal maintains its high standard by overseeing the peer review process and selecting only the most groundbreaking and relevant research for publication.
Topics Covered[edit | edit source]
The Annals of Oncology covers a wide range of topics within the field of oncology, including:
- Clinical trials
- Molecular biology
- Biomarkers
- Targeted therapies
- Palliative care
External Links[edit | edit source]
  | This article about an oncology journal is a stub. You can help WikiMD by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
| This article is a stub. You can help WikiMD by registering to expand it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen
